← All diseases Infectious diseases

Chronic hepatitis B

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (82)Meta-analysis (26)Treatment guideline (6)Randomized trial (32)Systematic review (10)Phase 3 study (8)Clinical trial (630)Review article (169)Early study (phase 1 or 2) (25)Case reports (96)Laboratory or animal research (16)Commentary or Editorial (50)Retracted publication (2) Studies currently recruiting participants only (31)

Filter

Publications and studies (2004)

• The sex-specific effects of blood lead, mercury, and cadmium levels on hepatic steatosis and fibrosis: Korean nationwide cross-sectional study. (2020/12/01) ♡
• Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index. (2020/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression. (2020/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe Non-Islet Cell Hypoglycemia From Ileum-Origin Gastrointestinal Stromal Tumor Producing Insulin-Like Growth Factor-2 in a Patient With Liver Cirrhosis Due to Chronic Hepatitis B. (2020/12/01) ♡
• Performance of FIB4 and APRI scores for the prediction of fibrosis in patients with chronic hepatitis B virus infection. (2020/12/01) ♡
• FIB-5 versus FIB-4 index for assessment of hepatic fibrosis in chronic hepatitis B affected patients (2020/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatitis B Virus: From Diagnosis to Treatment. (2020/12/01) ♡
• Chronic Hepatitis B and HIV Coinfection: A Continuing Challenge in the Era of Antiretroviral Therapy. (2020/12/01) ♡
• Smoking and Liver Disease. (2020/12/01) ♡
• Association between osteoporosis and hepatitis B cirrhosis: a case-control study. (2020/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Hepatic Lymphoma in a Patient with Chronic Hepatitis B. (2020/11/26) ♡
• CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice. (2020/11/26) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pembrolizumab-Induced Immune-Mediated Hepatitis and Concurrent Hepatitis B Reactivation in a Patient With Non-Small Cell Lung Cancer. (2020/11/17) ♡
• Improvement of human platelet aggregation post-splenectomy with paraesophagogastric devascularization in chronic hepatitis B patients with cirrhotic hypersplenism. (2020/11/16) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection. (2020/11/13) ♡
• Point Shear-Wave Elastography Using Acoustic Radiation Force Impulse Imaging for the Prediction of Liver-Related Events in Patients With Chronic Viral Hepatitis. (2020/11/12) ♡
• Evaluation for the Genetic Association between Store-Operated Calcium Influx Pathway (STIM1 and ORAI1) and Human Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection. (2020/11/09) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos (t) ide Analogues in HBeAg-negative CHB. (2020/11/05) ♡
• Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B. (2020/11/02) ♡
• Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice. (2020/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Long-Term Self-Expandable Metal Stent (SEMS) for Esophageal Variceal Bleeding: A Picture of the Natural History. (2020/11/01) ♡
• MODERN APPROACHES IN MANAGEMENT OF CHILDREN WITH CHRONIC HEPATITIS B IN REMISSION OF ACUTE LYMPHOBLASTIC LEUKEMIA. (2020/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An overview in management of hepatocellular carcinoma in Hong Kong using the Hong Kong Liver Cancer (HKLC) staging system. (2020/10/31) ♡
• Clinicohistological correlation of etiological spectrum of chronic liver disease diagnosed during noncirrhotic stages in children: Can need of liver biopsy be obviated? (2020/10/30) ♡
• Increased Expression of miR-487b Is Associated With Poor Prognosis and Tumor Progression of HBV-related Hepatocellular Carcinoma. (2020/10/19) ♡
• Clinical efficacy and safety of Ganshuang granules as an adjuvant treatment for chronic hepatitis B liver fibrosis: A protocol for systematic review and meta analysis. (2020/10/09) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mycotoxins in Ethiopia: A Review on Prevalence, Economic and Health Impacts. (2020/10/08) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Tenofovir may be superior to entecavir for preventing hepatocellular carcinoma and mortality in individuals chronically infected with HBV: a meta-analysis. (2020/10/01) ♡
• Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort. (2020/10/01) ♡
• Single center analysis of therapy and outcomes of hepatocellular carcinoma in Sub-Saharan Africa. (2020/10/01) ♡
• Peginterferon and Entecavir Combination Therapy Improves Outcome of Non-Early Response Hepatitis B and Antigen-Positive Patients. (2020/09/30) ♡
• A programme to treat chronic hepatitis B in Kiribati: progress and challenges. (2020/09/30) ♡
• A challenging case of alpha-fetoprotein result discrepancies in a patient with chronic hepatitis B. (2020/09/29) ♡
• Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis. (2020/09/28) ♡
• Genetic diversity of hepatitis B virus in Yunnan, China: identification of novel subgenotype C17, an intergenotypic B/I recombinant, and B/C recombinants. (2020/09/01) ♡
• Characterization of a novel hepatitis B virus subgenotype B10 among chronic hepatitis B patients in Yunnan, China. (2020/09/01) ♡
• Prevalence and clinical features of patients with concurrent HBsAg and anti-HBs: Evaluation of the hepatitis B research network cohort. (2020/09/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Refractory Chylous Ascites with Chylothorax and an Umbilical Hernia in a Patient Ineligible for a Transjugular Intrahepatic Portosystemic Shunt. (2020/08/31) ♡
• Skewed CD39/CD73/adenosine pathway contributes to B-cell hyperactivation and disease progression in patients with chronic hepatitis B. (2020/08/30) ♡
• Estimating hepatitis B virus cccDNA persistence in chronic infection. (2020/08/25) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients. (2020/08/14) ♡
• Association between liver cirrhosis and estimated glomerular filtration rates in patients with chronic HBV infection. (2020/08/14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multicenter, double-blind, randomized controlled trial in China. (2020/08/12) ♡
• Role of nutritional status and nutritional support in outcome of hepatitis B virus-associated acute-on-chronic liver failure. (2020/08/07) ♡
• Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium. (2020/07/27) ♡
• COLD-PCR Method for Early Detection of Antiviral Drug-Resistance Mutations in Treatment-Naive Children with Chronic Hepatitis B. (2020/07/18) ♡
• Nucleoside analogs assisted with Chinese compound prescription in treating hepatic fibrosis of chronic hepatitis B patients: A protocol of systematic review and meta-analysis. (2020/07/02) ♡
• Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology. (2020/07/01) ♡
• UHPLC coupled with mass spectrometry and chemometric analysis of Kang-Ai injection based on the chemical characterization, simultaneous quantification, and relative quantification of 47 herbal alkaloids and saponins. (2020/07/01) ♡
• Dietary habits and risk of hepatocellular carcinoma among hepatitis B surface antigen carriers: A prospective cohort study in China. (2020/07/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.